Pharmaceutical Product Risk and Recall Services
RQA supports product recall insurers and pharmaceutical companies before, during and after product incidents. We combine pharmaceutical quality and regulatory expertise with extensive experience in product recall, crisis management and incident response.
Understand pharmaceutical recall risk, strengthen preparedness and manage incidents effectively
Pharmaceutical recalls can involve significant patient-safety, regulatory, operational and financial consequences. The extent of the exposure depends not only on the nature of the product issue, but also on where the product has been distributed, the populations affected, the company’s ability to trace impacted batches and how quickly the organisation can investigate, make decisions and communicate with stakeholders.
For insurers, we provide an independent view of the risks associated with pharmaceutical manufacturers, importers and distributors, helping underwriting and risk teams understand potential recall exposure and the effectiveness of an insured’s controls.
For pharmaceutical companies, we help develop, review, train and test recall and crisis-management arrangements, so that teams can make informed decisions and respond effectively when an issue arises.
For Product Recall Insurers
Independent pharmaceutical risk insight to support underwriting and risk improvement
Understanding the recall exposure presented by a pharmaceutical company requires more than a general review of its operations.
Insurers need to understand what the company manufactures, imports or distributes; how product failures could affect patients; which markets and populations may be exposed; and whether the organisation has the systems and resources to identify, contain and manage an incident.
For Pharmaceutical Companies
Build recall arrangements that support patient safety, regulatory compliance and business continuity
A documented procedure is only one part of recall preparedness. Pharmaceutical companies also need people who understand their responsibilities, reliable information on which to base decisions and a team that can operate effectively during a fast-moving incident.
RQA provides practical, tailored support to pharmaceutical manufacturers, biotechnology businesses, importers, distributors and other life-sciences organisations.
Pharmaceutical recall risk requires a joined-up view
A pharmaceutical product issue rarely sits within one function. It may require rapid coordination between Quality Assurance, regulatory affairs, pharmacovigilance, manufacturing, supply chain, distribution, medical, legal, communications and senior management.
The potential impact can extend across multiple products, batches, markets and patient groups. A company may also need to coordinate with contract manufacturers, laboratories, logistics providers, wholesalers, healthcare professionals and regulatory authorities.
Effective pharmaceutical recall management therefore depends on:
- clear escalation and decision-making processes;
- reliable batch and distribution traceability;
- defined recall-team roles and deputies;
- appropriate quality and regulatory oversight;
- timely health-hazard and incident risk assessment;
- effective communications with regulators, customers and other stakeholders;
- tested procedures that work under pressure; and
- the ability to investigate root cause and implement corrective and preventive actions.
RQA brings these areas together to help insurers understand the risk and pharmaceutical businesses strengthen their ability to respond.
Pharmaceutical expertise across the product lifecycle
RQA can support organisations involved in:
- sterile and non-sterile pharmaceutical manufacturing;
- biotechnology and biosimilars;
- vaccines;
- cell and gene therapies;
- clinical-development and commercial products;
- pharmaceutical importation;
- storage, wholesale and distribution;
- contract manufacturing and outsourced operations;
- medical devices and combination products; and
- pharmaceutical supply-chain services.
Our wider pharmaceutical capability includes quality systems, GMP and GDP compliance, audits, inspection readiness, contamination control, validation, pharmacovigilance, QP/RP support, batch certification and EU importation.
This allows us to consider recall risk in the context of the company’s broader quality, regulatory and operational arrangements.
Why choose RQA?
⋅ Product recall and crisis-management experts
RQA specialises in product recall, product risk and crisis management, supporting manufacturers, insurers and legal teams before and during product incidents.
⋅ Pharmaceutical and regulatory expertise
Our consultants bring experience across pharmaceutical quality assurance, manufacturing, distribution, GMP/GDP compliance, regulatory affairs and specialist QP/RP activities.
⋅ Support for insurers and insured companies
We understand the different requirements of underwriters, risk engineers, claims teams and pharmaceutical businesses. Our work translates technical pharmaceutical risks into clear findings, practical recommendations and proportionate risk improvements.
⋅ Practical, tailored delivery
Every assignment is scoped around the organisation’s products, supply chain, markets, regulatory responsibilities and existing level of preparedness.
⋅ Global support
RQA works internationally through a network of more than 150 experienced consultants, providing access to appropriate expertise across markets and disciplines.
⋅ Independent perspective
Our independent assessments help insurers and pharmaceutical companies identify weaknesses that may be difficult to recognise from inside an organisation.
Discuss your pharmaceutical recall risks
Whether you are underwriting a pharmaceutical product recall risk, reviewing the preparedness of an insured company or strengthening your own recall and crisis-management arrangements, RQA can help.
Tell us about the organisation, products, markets or risks you need to assess, and we will help define an appropriate scope of support.